Matches in Nanopublications for { ?s ?p "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP934933.RAldVnXZO4AbKsjqzNSYdCEjLUVM6X27UoUckw3yUPIBc130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934933.RAldVnXZO4AbKsjqzNSYdCEjLUVM6X27UoUckw3yUPIBc130_provenance.
- NP377498.RACM2xu9s_Dxg709Rao9NBa1a68XQ8k5bfVAG_rNP0b6A130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377498.RACM2xu9s_Dxg709Rao9NBa1a68XQ8k5bfVAG_rNP0b6A130_provenance.
- NP299993.RAjQ2EslhzJEYe2IpJruQPyAksmA4U7p_yZvPtyHRsenI130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299993.RAjQ2EslhzJEYe2IpJruQPyAksmA4U7p_yZvPtyHRsenI130_provenance.
- NP341774.RAOC5Zeh-9y0C0KHGmdIK39zF1UnK3K5ZpiedBZhXA2Qk130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341774.RAOC5Zeh-9y0C0KHGmdIK39zF1UnK3K5ZpiedBZhXA2Qk130_provenance.
- NP867155.RAcd8IF3RVT1pdqcs2G94TyBgiDovXPqqJEHan3rs8GUk130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867155.RAcd8IF3RVT1pdqcs2G94TyBgiDovXPqqJEHan3rs8GUk130_provenance.
- assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP830441.RAcY0ZZXhcqlNeyIaqtXuKnuxJmS6mkK6Al4O-6oyo3rY130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830441.RAcY0ZZXhcqlNeyIaqtXuKnuxJmS6mkK6Al4O-6oyo3rY130_provenance.
- NP830442.RAhpbD44EC1pSPg445kl_VVfCTHKQkrzrtrVu-egtFf60130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830442.RAhpbD44EC1pSPg445kl_VVfCTHKQkrzrtrVu-egtFf60130_provenance.
- NP867180.RA-kVTbl5Trm1LeNPpQcFEAg442D-axLe_0GX7AOcpl-4130_assertion description "[We also show that JMJD2B and the hypoxia marker CA9 together stratify a subclass of breast cancer patients and predict a worse outcome of these breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867180.RA-kVTbl5Trm1LeNPpQcFEAg442D-axLe_0GX7AOcpl-4130_provenance.